Parkinson’s Disease

Edward Weidenfeld, Reagan Attorney & DC Socialite Who Went From Capitol Hill To Cannabis Entrepreneur Dies At 79

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease

AbbVie Walks Away From Parkinson's Drug Pact With BioArctic

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease

AbbVie Walks Away From Parkinson's Drug Pact With BioArctic

Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program

Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs

Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program

Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs

Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs

4D Pharma To Test Its Single-Strain Live Biotherapeutics In Parkinson's Disease

Parkinson’s Disease Recent News

FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease

Annovis Bio Inc (NYSE: ANVS) has

Yumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Disease

Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data

Why Did BioVie Shares Jump 21% Today?

EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo

Annovis Bio Inc (NYSE: ANVS) has announced efficacy data from the Phase 2 trial evaluating ANVS401 in Parkinson's disease (PD). Data from 54 patients found that once-daily ANVS401 was superior to placebo in improving motor function.

Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate

Stealth Bio Posts Encouraging Preclinical Data In Parkinson's Animal Studies

Gain Therapeutics' Gaucher, Parkinson's Candidate Shows Potential In Patient-Derived iPSC Study

Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial

AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration

Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis

IBM, Michael J. Fox Foundation Using Artificial Intelligence To Fight Parkinson's Disease

In 2000, actor Michael J. Fox launched The Michael J. Fox Foundation (MJFF) for Parkinson’s Research and became one of the most well-known spokesmen for finding a cure for the condition.

AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate

AC Immune SA (NASDAQ: ACIU) has gained a multi-million investment from the principal backers of BioNTech SE (NASDAQ: BNTX) while acquiring a possible Parkinson's disease vaccine.

Inhibikase To Start Testing Its Parkinson's Candidate In Patients

Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med

Ipsen In-Licenses Parkinson's Candidate From IRLAB

Seelos' Single Dose Of SLS-004 Shows Reduction In Parkinson's Associated mRNA, Protein Expression

Addex Therapeutics Starts Mid-Stage Study For Dipraglurant In Parkinson's Associated Dyskinesia

Anavex Life Sciences Stock Jumps As Blarcamesine Shows Convincing Biomarker-Correlating Efficacy Data In Parkinson's Disease, Dementia Patients

AbbVie, Caraway Therapeutics Team Up To Develop TMEM175 Modulators For Parkinson's Disease

FDA Gives Thumbs Down to Add Parkinson's Disease Assessments In Verily's Smartwatch

Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials

Annovis' Alzheimer's/Parkinson's Candidate Protects Nerve Cells Against Ill Effects of Higher Neurotoxic Proteins